Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
GPLD1
Introduction
Phosphatidylinositol-glycan-specific phospholipase D is an enzyme that in humans is encoded by the GPLD1 gene.[1][2]
Many proteins are tethered to the extracellular face of eukaryotic plasma membranes by a glycosylphosphatidylinositol (GPI) anchor. The GPI-anchor is a glycolipid found on many blood cells. The protein encoded by this gene is a GPI degrading enzyme. Glycosylphosphatidylinositol specific phospholipase D1 hydrolyzes the inositol phosphate linkage in proteins anchored by phosphatidylinositol glycans, thereby releasing the attached protein from the plasma membrane.[2]
References
References
- ↑ Schofield JN, Rademacher TW (Dec 2000). “Structure and expression of the human glycosylphosphatidylinositol phospholipase D1 (GPLD1) gene”. Biochim Biophys Acta. 1494 (1–2): 189–94. doi:10.1016/s0167-4781(00)00194-9. PMID 11072085.
- ↑ 2.0 2.1 “Entrez Gene: GPLD1 glycosylphosphatidylinositol specific phospholipase D1”.
- ↑ 3.0 3.1 Deeg, M A; Bierman E L; Cheung M C (Mar 2001). “GPI-specific phospholipase D associates with an apoA-I- and apoA-IV-containing complex”. J. Lipid Res. United States. 42 (3): 442–51. ISSN 0022-2275. PMID 11254757.
Further reading
Further reading
- Hoener MC, Brodbeck U (1992). “Phosphatidylinositol-glycan-specific phospholipase D is an amphiphilic glycoprotein that in serum is associated with high-density lipoproteins”. Eur. J. Biochem. 206 (3): 747–57. doi:10.1111/j.1432-1033.1992.tb16981.x. PMID 1606959.
- Scallon BJ, Fung WJ, Tsang TC, et al. (1991). “Primary structure and functional activity of a phosphatidylinositol-glycan-specific phospholipase D”. Science. 252 (5004): 446–8. Bibcode:1991Sci…252..446S. doi:10.1126/science.2017684. PMID 2017684.
- Metz CN, Brunner G, Choi-Muira NH, et al. (1994). “Release of GPI-anchored membrane proteins by a cell-associated GPI-specific phospholipase D”. EMBO J. 13 (7): 1741–51. PMC 395007. PMID 7512501.
- Jinnai H, Nakamura S (2000). “Characterization of phospholipase D activation by GM2 activator in a cell-free system”. Kobe Journal of Medical Sciences. 45 (3–4): 181–90. PMID 10752311.
- Deeg MA, Bierman EL, Cheung MC (2001). “GPI-specific phospholipase D associates with an apoA-I- and apoA-IV-containing complex”. J. Lipid Res. 42 (3): 442–51. PMID 11254757.
- Tang J, Li W (2002). “[Methodological study on the assay of glycosylphosphatidylinositol-specific phospholipase D activity in serum]”. Hunan Yi Ke Da Xue Xue Bao. 24 (2): 119–22. PMID 11938765.
- Slomiany A, Nishikawa H, Slomiany BL (2002). “Screening and modulation of extracellular signals by mucous barrier. Serum glycosylphosphatidylinositol phospholipase D (GPI-PLD) releases protective mucous barrier from oral mucosa”. J. Physiol. Pharmacol. 53 (1): 21–38. PMID 11939716.
- Jaworek J, Bonio J, Leja-Szpa A, et al. (2002). “Sensory nerves in central and peripheral control of pancreatic integrity by leptin and melatonin”. J. Physiol. Pharmacol. 53 (1): 51–74. PMID 11939719.
- Deeg MA, Bowen RF (2002). “Phosphorylation decreases trypsin activation and apolipoprotein al binding to glycosylphosphatidylinositol-specific phospholipase D”. Biochem. Cell Biol. 80 (2): 253–60. doi:10.1139/o02-004. PMID 11989719.
- Xiaotong H, Hannocks MJ, Hampson I, Brunner G (2002). “GPI-specific phospholipase D mRNA expression in tumor cells of different malignancy”. Clin. Exp. Metastasis. 19 (4): 291–9. doi:10.1023/A:1015545407700. PMID 12090469.
- Magnusson P, Sharp CA, Farley JR (2003). “Different distributions of human bone alkaline phosphatase isoforms in serum and bone tissue extracts”. Clin. Chim. Acta. 325 (1–2): 59–70. doi:10.1016/S0009-8981(02)00248-6. PMID 12367767.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). “Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences”. Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. Bibcode:2002PNAS…9916899M. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Tang JH, Gu SL, Zhang XJ (2003). “[Preliminary study of the gene structure of human glycosylphosphatidylinositol specific phospholipase D]”. Hunan Yi Ke Da Xue Xue Bao. 26 (2): 95–7. PMID 12536633.
- Mungall AJ, Palmer SA, Sims SK, et al. (2003). “The DNA sequence and analysis of human chromosome 6”. Nature. 425 (6960): 805–11. doi:10.1038/nature02055. PMID 14574404.
- Kurtz TA, Fineberg NS, Considine RV, Deeg MA (2004). “Insulin resistance is associated with increased serum levels of glycosylphosphatidylinositol-specific phospholipase D”. Metab. Clin. Exp. 53 (2): 138–9. doi:10.1016/j.metabol.2003.09.004. PMID 14767861.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). “The Status, Quality, and Expansion of the NIH Full-Length cDNA Project: The Mammalian Gene Collection (MGC)”. Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMC 528928. PMID 15489334.
- Lugli EB, Pouliot M, Portela Mdel P, et al. (2005). “Characterization of primate trypanosome lytic factors”. Mol. Biochem. Parasitol. 138 (1): 9–20. doi:10.1016/j.molbiopara.2004.07.004. PMID 15500911.
- Everett PB, Senogles SE (2005). “D3 dopamine receptor activates phospholipase D through a pertussis toxin-insensitive pathway”. Neurosci. Lett. 371 (1): 34–9. doi:10.1016/j.neulet.2004.08.033. PMID 15500962.
- Mead KI, Zheng Y, Manzotti CN, et al. (2005). “Exocytosis of CTLA-4 is dependent on phospholipase D and ADP ribosylation factor-1 and stimulated during activation of regulatory T cells”. J. Immunol. 174 (8): 4803–11. doi:10.4049/jimmunol.174.8.4803. PMID 15814706.